![](/img/cover-not-exists.png)
Studies with abanoquil (UK-52,046) a novel quinoline alpha 1- adrenoceptor antagonist: II. Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjects.
RF Schafers, HL Elliott, PA Meredith, SH Miller, JL ReidVolume:
32
Year:
1991
Language:
english
DOI:
10.1111/j.1365-2125.1991.tb03959.x
File:
PDF, 1.07 MB
english, 1991